Correlation Between Various Adipokines and Vascular Inflammation Measured by Positron Emission Tomography (PET) With 18F-fluoro-deoxyglucose (FDG) (18FDG-PET)
- Conditions
- Atherosclerosis
- Interventions
- Other: Cross sectional study
- Registration Number
- NCT01150006
- Lead Sponsor
- Korea University
- Brief Summary
The inflammatory state and composition of atherosclerotic plaques are considered the main contributing factors responsible for acute cardiovascular events, rather than the degree of stenosis. Recently, positron emission tomography (PET) with 18F-fluoro-deoxyglucose (FDG) has been suggested as a promising novel imaging technique to identify the inflammatory state of atherosclerotic plaque. Recently, a few clinical studies showed that circulating A-FABP level had a close relation with the development of atherosclerosis in human. Therefore, in the present study, the investigators examined the relationship between circulating A-FABP and vascular inflammation of carotid arteries measured using FDG-PET in healthy male subjects.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- Male
- Target Recruitment
- 90
- Healthy male volunteers for visiting routine medical check in our clinic
- History of cardiovascular disease (myocardial infarction, unstable angina,stroke, or cardiovascular revascularization)
- Diabetes
- Hypertension
- Malignancy
- Severe renal or hepatic disease
- Subjects taking medications that might affect inflammation such as NSIAD and statin
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Healthy male participants Cross sectional study -
- Primary Outcome Measures
Name Time Method Vascular inflammation in carotid arterial wall, represented as the target-to-background ratio (TBR), using FDG-PET 12 weeks
- Secondary Outcome Measures
Name Time Method Circulating serum leptin levels 12weeks Circulating serum adiponectin levels 12 weeks Carotid intima-media thickness levels measured using ultrasonography 12 weeks Circulating serum A-FABP levels 12 weeks
Trial Locations
- Locations (1)
Hye Jin Yoo
🇰🇷Seoul, Korea, Republic of